Recursion Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | 49.8% | 49.8% | — |
| FY2020 | 42.2% | 42.2% | -29.1% |
| FY2021 | -34.3% | -34.3% | -30.6% |
| FY2022 | -49.3% | -49.3% | -34.1% |
| FY2023 | -70.8% | -70.6% | -50.2% |
| FY2024 | -44.8% | -44.0% | -32.0% |
| FY2025 | -57.0% | -56.5% | -43.7% |